C. Estes
Epidemiology · 2014–2018
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Epidemiology — 57 citations into it; #1,663 of 2,148 by trust here, #681 by citations
- Hepatology — 51 citations into it; #97 of 151 by trust here, #79 by citations
Whom C. Estes trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Z. Younossi
- D. Lavanchy
- M. Rinella
- D. Kleiner
- Christopher D. Byrne
- R. Loomba
- Jordi Bruix1 , 2
- A. Sanyal
Who trusts C. Estes overall
Papers from C. Estes's perspective
Ordered by how strongly the researchers C. Estes trusts endorse each paper. Same corpus, a different order for every researcher.
- Non-Alcoholic Fatty Liver Disease and Hepatocellular Cancer: A Systematic Review (Clinical Gastroenterology and Hepatology)
- Nonalcoholic fatty liver disease. (Revista de Gastroenterología de México)
- Nonalcoholic fatty liver disease: a systematic review. (Journal of the American Medical Association (JAMA))
- NAFLD: a multisystem disease. (Journal of Hepatology)
- Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. (American Journal of Epidemiology)
- USE OF THE FIB4 INDEX FOR NON-INVASIVE EVALUATION OF FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE (Clinical Gastroenterology and Hepatology)
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. (Hepatology)
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe (Hepatology)
- Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. (Clinical Gastroenterology and Hepatology)
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Their papers
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. (2018) — 1,677 citations
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. (2018) — 1,437 citations
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. (2017) — 1,848 citations
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease (2017) — 2,091 citations
- Global epidemiology and genotype distribution of the hepatitis C virus infection. (2014) — 1,968 citations